In summary, we suggested for the first time that EIF3C is upregulated in lung cancer tissues and may enhance the proliferation and suppress the apoptosis of lung cancer cells by regulating the APP/HSPA1A/LMNB1 axis. Here, APP is linked to lung carcinoma.